The Natural Cytotoxicity Receptors in Health and Disease

被引:275
作者
Barrow, Alexander David [1 ]
Martin, Claudia Jane [1 ]
Colonna, Marco [2 ]
机构
[1] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
关键词
receptors; natural killer cell; immunoregulation; disease association; tissue homeostasis; INNATE LYMPHOID-CELLS; APOPTOSIS-INDUCING LIGAND; UTERINE NK CELLS; MHC CLASS-I; HEPARAN-SULFATE PROTEOGLYCANS; VIRUS-INFECTED CELLS; KILLER-CELLS; ACTIVATING RECEPTOR; T-CELLS; CRYSTAL-STRUCTURE;
D O I
10.3389/fimmu.2019.00909
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Natural Cytotoxicity Receptors (NCRs), NKp46, NKp44, and NKp30, were some of the first human activating Natural Killer (NK) cell receptors involved in the non-MHC-restricted recognition of tumor cells to be cloned over 20 years ago. Since this time many host-and pathogen-encoded ligands have been proposed to bind the NCRs and regulate the cytotoxic and cytokine-secreting functions of tissue NK cells. This diverse set of NCR ligands can manifest on the surface of tumor or virus-infected cells or can be secreted extracellularly, suggesting a remarkable NCR polyfunctionality that regulates the activity of NK cells in different tissue compartments during steady state or inflammation. Moreover, the NCRs can also be expressed by other innate and adaptive immune cell subsets under certain tissue conditions potentially conferring NK recognition programs to these cells. Here we review NCR biology in health and disease with particular reference to how this important class of receptors regulates the functions of tissue NK cells as well as confer NK cell recognition patterns to other innate and adaptive lymphocyte subsets. Finally, we highlight how NCR biology is being harnessed for novel therapeutic interventions particularly for enhanced tumor surveillance.
引用
收藏
页数:20
相关论文
共 215 条
[1]   Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors [J].
Ahola-Olli, Ari V. ;
Wurtz, Peter ;
Havulinna, Aki S. ;
Aalto, Kristiina ;
Pitkanen, Niina ;
Lehtimaki, Terho ;
Kahonen, Mika ;
Lyytikainen, Leo-Pekka ;
Raitoharju, Emma ;
Seppala, Ilkka ;
Sarin, Antti-Pekka ;
Ripatti, Samuli ;
Palotie, Aarne ;
Perola, Markus ;
Viikari, Jorma S. ;
Jalkanen, Sirpa ;
Maksimow, Mikael ;
Salomaa, Veikko ;
Salmi, Marko ;
Kettunen, Johannes ;
Raitakari, Olli T. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2017, 100 (01) :40-50
[2]   Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β [J].
Alba, A. ;
Planas, R. ;
Clemente, X. ;
Carrillo, J. ;
Ampudia, R. ;
Puertas, M. -C. ;
Pastor, X. ;
Tolosa, E. ;
Pujol-Borrell, R. ;
Verdaguer, J. ;
Vives-Pi, M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 151 (03) :467-475
[3]   Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept [J].
Almeida, Afonso R. ;
Correia, Daniel V. ;
Fernandes-Platzgummer, Ana ;
da Silva, Claudia L. ;
da Silva, Maria Gomes ;
Anjos, Diogo Remechido ;
Silva-Santos, Bruno .
CLINICAL CANCER RESEARCH, 2016, 22 (23) :5795-5804
[4]   Role of platelet-derived growth factors in physiology and medicine [J].
Andrae, Johanna ;
Gallini, Radiosa ;
Betsholtz, Christer .
GENES & DEVELOPMENT, 2008, 22 (10) :1276-1312
[5]  
[Anonymous], EUR J IMMUNOL
[6]  
[Anonymous], IMMUNITY
[7]  
[Anonymous], J LEUKOC BIOL
[8]  
[Anonymous], J CARDIOVASC PHARM
[9]  
[Anonymous], GENE THER
[10]   Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus [J].
Arnon, TI ;
Achdout, H ;
Levi, O ;
Markel, G ;
Saleh, N ;
Katz, G ;
Gazit, R ;
Gonen-Gross, T ;
Hanna, J ;
Nahari, E ;
Porgador, A ;
Honigman, A ;
Plachter, B ;
Mevorach, D ;
Wolf, DG ;
Mandelboim, O .
NATURE IMMUNOLOGY, 2005, 6 (05) :515-523